101 related articles for article (PubMed ID: 22155876)
1. Thrombocytosis and hematocrit as prognostic factors in renal carcinoma.
Seda CJ; Salas AS; Sánchez CG; Blasco JM; García IO; Sánchez JM; Ruíz CB; Navarro SM; López RA
Arch Esp Urol; 2011 Nov; 64(9):883-90. PubMed ID: 22155876
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of thrombocytosis in renal cell carcinoma.
Bensalah K; Leray E; Fergelot P; Rioux-Leclercq N; Tostain J; Guillé F; Patard JJ
J Urol; 2006 Mar; 175(3 Pt 1):859-63. PubMed ID: 16469566
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM
Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of thrombocytosis in renal cell carcinoma patients.
Inoue K; Kohashikawa K; Suzuki S; Shimada M; Yoshida H
Int J Urol; 2004 Jun; 11(6):364-7. PubMed ID: 15157203
[TBL] [Abstract][Full Text] [Related]
6. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
8. Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
Wosnitzer M; Polland A; Hai Q; Hruby G; McKiernan J
BJU Int; 2011 Jul; 108(1):73-9. PubMed ID: 21166746
[TBL] [Abstract][Full Text] [Related]
9. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
Karakiewicz PI; Trinh QD; Lam JS; Tostain J; Pantuck AJ; Belldegrun AS; Patard JJ
Eur Urol; 2007 Nov; 52(5):1428-36. PubMed ID: 17420085
[TBL] [Abstract][Full Text] [Related]
10. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
11. High platelet count multiplies risk following renal cell carcinoma treatment.
Urol Nurs; 2001 Jun; 21(3):224-5. PubMed ID: 11998657
[No Abstract] [Full Text] [Related]
12. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
13. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
14. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.
Göğüş C; Baltaci S; Filiz E; Elhan A; Bedük Y
Urology; 2004 Mar; 63(3):447-50. PubMed ID: 15028435
[TBL] [Abstract][Full Text] [Related]
15. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytosis in advanced epithelial ovarian cancer.
Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
Lee SE; Byun SS; Han JH; Han BK; Hong SK
BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
[TBL] [Abstract][Full Text] [Related]
19. Poor Prognosis Associated with High Levels of Thymidine Phosphorylase and Thrombocytosis in Patients with Renal Cell Carcinoma.
Huang X; Wang L; Chen Y; Zheng X; Wang X
Urol Int; 2017; 98(2):162-168. PubMed ID: 27532673
[TBL] [Abstract][Full Text] [Related]
20. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.
Brockmann MA; Giese A; Mueller K; Kaba FJ; Lohr F; Weiss C; Gottschalk S; Nolte I; Leppert J; Tuettenberg J; Groden C
Neuro Oncol; 2007 Jul; 9(3):335-42. PubMed ID: 17504931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
